Hereditary Diffuse Gastric Cancer: Prophylactic Surgical Oncology Implications

Surgical Clinics of North America

Volumn 88, Issue 4, 2008, Pages 759-778

  Lynch, Henry T ^a   Silva, Edibaldo ^b   Wirtzfeld, Debrah ^c   Hebbard, Pamela ^c   Lynch, Jane ^a   Huntsman, David G ^d,e  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HEPARIN; UVOMORULIN;

ABDOMINAL ABSCESS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIAGNOSTIC IMAGING; ESOPHAGOGASTRODUODENOSCOPY; FAMILIAL CANCER; GENE MUTATION; GENETIC SCREENING; HEMATOMA; HETEROZYGOTE DETECTION; HUMAN; INTERNAL HERNIA; LUNG EMBOLISM; METASTASIS; MORBIDITY; PATHOGENESIS; PATIENT DECISION MAKING; PERCUTANEOUS DRAINAGE; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SPLEEN INFARCTION; SPLENIC VEIN; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CANCER; SURGICAL TECHNIQUE; TOTAL STOMACH RESECTION; VEIN THROMBOSIS;

GASTRECTOMY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 47849089452     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.04.006     Document Type: Review

References (61)

1. Alberts S.R., Cervantes A., and van De Velde C.J. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14 Suppl 2 (2003) ii31-ii36
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
3. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64 (1965) 31-49
4. Jones E.G. Familial gastric cancer. N Z Med J 63 (1964) 287-296
5. Guilford P., Hopkins J., Harraway J., et al. E-cadherin germline mutations in familial gastric cancer. Nature 392 (1998) 402-405
6. Kaurah P., MacMillan A., Boyd N., et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297 (2007) 2360-2372
7. Keller G., Vogelsang H., Becker I., et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155 (1999) 337-342
8. Schrader K.A., Masciari S., Boyd N., et al. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 7 (2008) 73-82
9. Suriano G., Oliveira C., Ferreira P., et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 12 (2003) 575-582
10. Pharoah P.D.P., Guilford P., Caldas C., et al. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121 (2001) 1348-1353
11. MacDonald D.J., and Lessick M. Hereditary cancers in children and ethical and psychosocial implications. J Pediatr Nurs 15 (2000) 217-225
12. Caldas C., Carneiro F., Lynch H.T., et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 36 (1999) 873-880
13. Suriano G., Yew S., Ferreira P., et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 11 (2005) 5401-5409
14. Brooks-Wilson A.R., Kaurah P., Suriano G., et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 41 (2004) 508-517
15. Mullins F., Dietz L., Lay M., et al. Identification of an intronic single nucleotide polymorphism leading to allele dropout during validation of a CDH1 sequencing assay: implications for designing polymerase chain reaction-based assays. Genet Med 9 (2007) 752-760
16. Norton J.A., Ham C.M., Van Dam J., et al. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 245 (2007) 873-879
17. Lewis F.R., Mellinger J.D., Hayashi A., et al. Prophylactic total gastrectomy for familial gastric cancer. Surgery 130 (2001) 612-617
18. Bacani J.T., Soares M., Zwingerman R., et al. CDH1/E-cadherin germline mutations in early onset gastric cancer. J Med Genet 43 (2006) 867-872
19. Huntsman D.G., Carneiro F., Lewis F.R., et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 344 (2001) 1904-1909
20. Lynch H.T. Family Information Service and hereditary cancer. Cancer 91 (2001) 625-628
21. Lynch H.T., Grady W., Lynch J.F., et al. E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma. Cancer Genet Cytogenet 122 (2000) 1-6
22. Carneiro F., Huntsman D.G., Smyrk T.C., et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203 (2004) 681-687
23. Humar B., Fukuzawa R., Blair V., et al. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res 67 (2007) 2480-2489
24. Lynch H.T., Kaurah P., Wirtzfeld D., et al. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer 112 (2008) 2655-2663
25. Gayther S.A., Gorringe K.L., Ramus S.J., et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58 (1998) 4086-4089
26. Hartgrink H.H., van De Velde C.J., Putter H., et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22 (2004) 2069-2077
27. Rebbeck T.R., Lynch H.T., Neuhausen S.L., et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346 (2002) 1616-1622
28. National Cancer Institute. Genetics of medullary thyroid cancer (PDQ): health professional version. Available at:. http://www.cancer.gov/cancertopics/pdq/genetics/medullarythyroid/HealthProfessional/allpages AccessedMarch 11, 2008
29. Schmeler K.M., Lynch H.T., Chen L.-M., et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354 (2006) 261-269
30. Lynch H.T. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers?. Dis Colon Rectum 39 (1996) 109-110
31. Hartmann L.C., Sellers T.A., Schaid D.J., et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93 (2001) 1633-1637
32. Rebbeck T.R., Levin A.M., Eisen A., et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91 (1999) 1475-1479
33. Lynch H.T., Silva E., Snyder C., et al. Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes. Breast J 14 (2008) 3-13
34. Silva E., Gatalica Z., Snyder C., et al. Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology. Breast J 14 (2008) 14-24
35. Silva E. Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist. Fam Cancer 7 (2008) 91-95
36. Guillem J.G., Wood W.C., Moley J.F., et al. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24 (2006) 4642-4660
37. Guilford P., Blair V., More H., et al. A short guide to hereditary diffuse gastric cancer. Hereditary Cancer in Clinical Practice 5 (2007) 183-194
38. Lynch H.T., Grady W., Suriano G., et al. Gastric cancer: new genetic developments. J Surg Oncol 90 (2005) 114-133
39. Seufert R.M., Schmidt-Matthiesen A., and Beyer A. Total gastrectomy and oesophagojejunostomy-a prospective randomized trial of hand-sutured versus mechanically stapled anastomoses. Br J Surg 77 (1990) 50-52
40. Fujimoto S., Takahashi M., Endoh F., et al. Stapled or manual suturing in esophagojejunostomy after total gastrectomy: a comparison of outcome in 379 patients. Am J Surg 162 (1991) 256-259
41. Hyodo M., Hosoya Y., Hirashima Y., et al. Minimum leakage rate (0.5%) of stapled esophagojejunostomy with sacrifice of a small part of the jejunum after total gastrectomy in 390 consecutive patients. Dig Surg 24 (2007) 169-172
42. Lehnert T., and Buhl K. Techniques of reconstruction after total gastrectomy for cancer. Br J Surg 91 (2004) 528-539
43. Braga M., Zuliani W., Foppa L., et al. Food intake and nutritional status after total gastrectomy: results of a nutritional follow-up. Br J Surg 75 (1988) 477-480
44. Buhl K., Lehnert T., Schlag P., et al. Reconstruction after gastrectomy and quality of life. World J Surg 19 (1995) 558-564
45. Sharma D. Choice of digestive tract reconstructive procedure following total gastrectomy: a critical reappraisal. Indian J Surg 66 (2004) 270-276
46. Liedman B., Bosaeus I., Hugosson I., et al. Long-term beneficial effects of a gastric reservoir on weight control after total gastrectomy: a study of potential mechanisms. Br J Surg 85 (1998) 542-547
47. Bozzetti F., Bonfanti G., Castellani R., et al. Comparing reconstruction with Roux-en-Y to a pouch following total gastrectomy. J Am Coll Surg 183 (1996) 243-248
48. Tanaka T., Fujiwara Y., Nakagawa K., et al. Reflux esophagitis after total gastrectomy with jejunal pouch reconstruction: comparison of long and short pouches. Am J Gastroenterol 92 (1997) 821-824
49. Kajitani T. Japanese Research Society for the Study of Gastric Cancer. The general rules for Gastric Cancer Study in Surgery and Pathology. Jpn J Surg 11 (1981) 127-145
50. Kitagawa Y., Fujii H., Mukai M., et al. Radio-guided sentinel node detection for gastric cancer. Br J Surg 89 (2002) 604-608
51. Hayashi H., Ochiai T., Mori M., et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg 196 (2003) 68-74
52. Beitsch P.D., Clifford E., Whitworth P., et al. Improved lymphatic mapping technique for breast cancer. Breast J 7 (2001) 219-223
53. Chagpar A., Martin III R.C., Chao C., et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 139 (2004) 614-618
54. McMasters K.M., Wong S.L., Martin II R.C., et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233 (2001) 676-687
55. Macdonald J.S. Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol 90 (2005) 166-170
56. Kodera Y., Nakanishi H., Ito S., et al. Detection of disseminated cancer cells in linitis plastica-type gastric carcinoma. Jpn J Clin Oncol 34 (2004) 525-531
57. Yachida S., Fukushima N., Sakamoto M., et al. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer. Br J Surg 89 (2002) 573-578
58. Francis A., England D.W., Rowlands D.C., et al. The diagnosis of invasive lobular breast carcinoma. Does MRI have a role?. Breast 10 (2001) 38-40
59. Chung M.A., and Cady B. Re: genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations. Breast J 12 (2006) 282-283
60. van Kouwen M.C., Drenth J.P., Oyen W.J., et al. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. Clin Cancer Res 10 (2004) 6456-6459
61. Shaw D., Blair V., Framp A., et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?. Gut 54 (2005) 461-468